Grand River Aseptic Manufacturing

06/03/2026

Grand River Aseptic Manufacturing supports fill-finish programs with sterile filling capabilities for liquid and lyophilized vials, prefilled syringes, and cartridges. With five isolator-based filling lines, experienced operators, and established quality practices, GRAM supports programs that require strong contamination control strategies, scalable capacity, and reliable performance from clinical through commercial supply.

Hear from our team member and see how GRAM is helping pharmaceutical and biotechnology companies navigate evolving injectable product pipelines with confidence. 🔸 https://hubs.la/Q04gpp6W0

A sterile injectable CDMO providing fill‑and‑finish services across vials, syringes, and cartridges, supported by isolator-based filling lines and biologics-ready scale.

05/21/2026

Grand River Aseptic Manufacturing is heading to Philadelphia for CPHI Americas! Connect with our team to discuss sterile injectable drug product manufacturing at booth 1200, and don't miss our happy hour on Wednesday from 3-5 pm 🍻🍷

05/19/2026

Sustainability news! 🌱 We’re honored to receive the 2026 Greenovation™ Award from Ansell for our commitment to landfill diversion through The RightCycle™ Program.

This award recognizes those who demonstrate sustainability leadership and take proactive steps to reduce their environmental impact. In total, throughout the life of our program, Grand River Aseptic Manufacturing diverted 46,000+ pounds of PPE waste from landfills, giving these materials a second life.

Together, we’re moving closer to zero‑waste goals. Congrats to this year’s winners!

05/12/2026

Join Grand River Aseptic Manufacturing at CDMO Live Europe to discuss sterile injectable manufacturing and drug delivery solutions for pharmaceutical and biotechnology partners. We look forward to connecting on your fill-finish needs. Visit booth S18 at CDMO Live Europe!

05/07/2026

Discover our newest syringe and cartridge filling capability for the growing biologics market—built to deliver precise control of critical drug‑device parameters at medium to high volumes.

Featuring the Groninger USA UFVN syringe filler with SKAN isolator technology for advanced sterility assurance and consistent ISO-compliant performance.

https://hubs.la/Q04dWXxc0

05/01/2026

CEO Denis Johnson recently spoke with Crain's Grand Rapids Business about GRAM’s continued expansion in both facilities and talent. https://hubs.la/Q04f257d0

Investment will expanding the company's capacity to fill syringes and cartridges for pharmaceutical clients.

04/17/2026

Stay current on Grand River Aseptic Manufacturing's U.S.-based sterile filling capacity in this webinar 🎤💉

https://hubs.la/Q04bXLnj0

04/14/2026

Today, we announce a significant investment to expand GRAM's sterile injectable drug product manufacturing capacity and capabilities for high-volume commercial products.

GRAM has invested $100 million in its fifth sterile-filling line and fifth Good Manufacturing Practice (GMP) facility.

The new sterile filling line, a Groninger USA 10-head fill line equipped with a SKAN isolator, is designed to manufacture high-volume prefilled syringes and cartridges while ensuring compliance with evolving Annex 1 standards. The line will accommodate a variety of syringe sizes ranging from 1mL to 10mL, and cartridge sizes from 1.5mL to 20mL.

🎉Congratulations to both teams on the successful FAT for our groninger 10-head syringe and cartridge filling line!

Read the latest press release and watch a video from the FAT: https://hubs.la/Q04bXJmV0

03/31/2026

Tune in to the Outsourced Pharma Fill-Finish Capabilities Update in April to hear from Kevin Wess as he walks through the latest on GRAM’s sterile fill-finish capacity and how it can support your pipeline.

Stay current on U.S.-based CDMO capacity and inform your outsourcing strategy.
https://hubs.la/Q047-0wC0

03/31/2026

At Grand River Aseptic Manufacturing, we do not view Annex 1 as the end goal—it is our starting point. We use it as our foundation for building a modern sterility assurance program that anticipates how regulatory expectations will continue to evolve.

In our latest article, our Director of QA & Regulatory Affairs shares how GRAM moves beyond basic Annex 1 compliance to build more resilient, future-ready aseptic operations.

https://hubs.la/Q0496FrK0